High expression of the transcription factor c-Myb was found to repress the expression of a set of inflammatory signature genes in BC, including Ccl2, Cxcl1, cxcl2, cxcl6, Cxcl16, Icam1, Il1a, Tnfrsf9, Lcn2, and Ikbke, which were denoted as c-Myb-inflammatory signature [105]. This evidence concerns the gene CCL2 and breast cancer.